Cancer Stem Cells
The world's first and only industry-focused Cancer Stem Cells meetingMar 24,2010 - Mar 25,2010
Cambridge, Massachusetts, United States
-
Highlights
Understand research and drug development efforts of big pharma and large biotech companies like Pfizer, Genentech, MedImmune, Novartis, Bristol-Myers Squibb, Merck, AstraZeneca and Roche.
The world's most innovative biotechs such as OncoMed, Geron, Stemline Therapeutics, ImmunoCellular Therapeutics, Micromet, Fate Therapeutics and Cellerant Therapeutics outline how they are attacking or preventing cancer stem cells from taking hold, along with the very latest clinical updates.
Listen to pioneering research leaders and scientists, including Dr Robert Weinberg of the Whitehead Institute and Dr Piyush Gupta of the Broad Institute, as they describe the opportunities that breakthroughs in our understanding or cancer stem cells offer
Assess the opportunities for your business or research group in taking potentially revolutionary new cancer treatments to patients based on the cancer stem cell hypothesis.
Event Reminder
- Registration Open
- Call for Papers
- Call for Speakers
- Receive GTM eblast updates
- Security Code:
Event Profile
- Theme: The world's first and only industry-focused Cancer Stem Cells meeting
Contact Details
- Contact person: Tom Richardson
- Event website: http://www.hansonwade.com/events/cancer-stem-cells/index.shtml
- Phone: +44 203 141 8700
- Fax: +44 203 008 3140
Tags
- Tag: Cancer Stem Cells Oncology Development
Contact Organizer
